Mirae Asset Healthcare
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation14.1%
Maximum Drawdown-15.3% | Jan 2025
Sharpe Ratio0.94
Beta0.91
Upside Capture95%
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices10.15%
Divi's Laboratories LtdServices9.79%
Torrent Pharmaceuticals LtdServices6.80%
Apollo Hospitals Enterprise LtdServices5.62%
Laurus Labs LtdServices5.51%
Dr Reddy's Laboratories LtdServices4.84%
Glenmark Pharmaceuticals LtdServices4.78%
Aurobindo Pharma LtdServices3.78%
Alkem Laboratories LtdServices3.76%
Ipca Laboratories LtdServices3.39%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.04%
Exit Load1%
Regulatory & Tax Information
INF769K01EA2
ISINDailyDealing Frequency
BSE Healthcare PR INRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)